Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

Jesse C. Seegmiller; Emily L. Kokaisel; Steven J. Story; Christopher P. Zaun; Jennifer M. Peters; Stefani N. Thomas; Amy B. Karger

doi:10.1016/j.clinbiochem.2020.08.004

Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

Jesse C. Seegmiller
, Emily L. Kokaisel
, Steven J. Story
, Christopher P. Zaun
, Jennifer M. Peters
, Stefani N. Thomas
, Amy B. Karger

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	34-35
Number of pages	2
Journal	Clinical Biochemistry
Volume	86
DOIs	https://doi.org/10.1016/j.clinbiochem.2020.08.004
State	Published - Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antibody
COVID-19
Comparison
ELISA
SARS-CoV-2
Serology

Publisher link

10.1016/j.clinbiochem.2020.08.004

Find It

Find It at U of M Libraries

Cite this

@article{d6ae00446c7944118ccd1bd304f058d6,

title = "Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay",

keywords = "Antibody, COVID-19, Comparison, ELISA, SARS-CoV-2, Serology",

author = "Seegmiller, \{Jesse C.\} and Kokaisel, \{Emily L.\} and Story, \{Steven J.\} and Zaun, \{Christopher P.\} and Peters, \{Jennifer M.\} and Thomas, \{Stefani N.\} and Karger, \{Amy B.\}",

year = "2020",

month = dec,

doi = "10.1016/j.clinbiochem.2020.08.004",

language = "English (US)",

volume = "86",

pages = "34--35",

journal = "Clinical Biochemistry",

issn = "0009-9120",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

AU - Seegmiller, Jesse C.

AU - Kokaisel, Emily L.

AU - Story, Steven J.

AU - Zaun, Christopher P.

AU - Peters, Jennifer M.

AU - Thomas, Stefani N.

AU - Karger, Amy B.

PY - 2020/12

Y1 - 2020/12

KW - Antibody

KW - COVID-19

KW - Comparison

KW - ELISA

KW - SARS-CoV-2

KW - Serology

UR - https://www.scopus.com/pages/publications/85089598928

UR - https://www.scopus.com/pages/publications/85089598928#tab=citedBy

U2 - 10.1016/j.clinbiochem.2020.08.004

DO - 10.1016/j.clinbiochem.2020.08.004

M3 - Article

C2 - 32791053

AN - SCOPUS:85089598928

SN - 0009-9120

VL - 86

SP - 34

EP - 35

JO - Clinical Biochemistry

JF - Clinical Biochemistry

ER -

Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Cite this